ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Olympia Pharmaceuticals

Official 2024 U.S. DOL Form 5500 summary for Olympia Pharmaceuticals (Olympia Pharmaceuticals 401(k) Plan · EIN 46-3797500 · PN 001): $342,647 net assets, 203 active participants, and $65.11 per $10,000 (65.11 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorOlympia Pharmaceuticals
Filing IdentifierOlympia Pharmaceuticals 401(k) Plan · EIN 46-3797500 · PN 001
Plan Category & State401(k) Defined Contribution (FL)
Asset-Size Peer Cohort<$1M
Plan Net Assets (2024)$342,647
Active Participants203
Direct Admin Fee Rate$65.11 per $10,000 (65.11 bps)
Cohort Peer MedianN/A
Primary Recordkeeper / ProviderCapital Group / American Funds
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI